This article has been updated with information from Pathway clarifying the CancerIntercept test's current marketing in the US, and descibing how it will be available in Japan.

NEW YORK (GenomeWeb) – Pathways Genomics announced today that it has partnered with two affiliated Japanese firms — G-TAC and M3 — to market 14 of its cancer genetics and fitness genetics tests in Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.